Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
BTC vs ETH fundamentals: a side-by-side look at core strengths and weaknesses to inform your next move.
27,640 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
NRG Energy surges to the lead in 2025, driven by Larry Coben’s leadership and a strategy to pair robust gas-fired gen...
BuzzFeed wins a brief reprieve on a $5 million debt due May 18, after a prior going-concern warning. The move spooks ...
Samsung units are set to acquire a $408 million stake in Dunamu, the operator of Upbit, signaling a major push by dom...
Analysts argue the Micron rally isn’t over: AI memory demand and persistent supply tightness could propel shares high...
NVIDIA stock rose on speculation it is crafting a Groq-based AI chip to challenge Broadcom and Alphabet's TPU. Cramer...
Daiwa upgrades Qualcomm to Outperform, increasing the target to $225 as analysts forecast a broader AI infrastructure...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Austin reels after the death of Joshua Baer, the founder who helped mold the city’s tech economy. The loss raises que...
Regulatory tightening is reshaping crypto’s path. Barabash argues the most regulated platforms may become the biggest...
American Express is scrapping its long-standing unit-by-unit bonus race. The company now ties executive pay to overal...
Bari Weiss has been appointed as CBS News chief, launching a sweeping overhaul of 60 Minutes as part of a broader new...